Strategic Divestitures and Focus on Jupiter
The company announced a definitive agreement to divest its Massachusetts retail locations to In Good Health for $2 million, aiming to complete all plant-touching divestitures by the end of 2025. This will allow TILT to focus on its Jupiter business, positioning it for mainstream financing and potential U.S. exchange listings.
Growth in Jupiter Revenue
Jupiter's revenue increased to $17.4 million in Q4 2024, up from $16.8 million in Q3 2024, highlighting a positive trend in its hardware business despite year-over-year declines.
Improved Gross Margin
Gross margin for Q4 2024 increased to 22% from 14% in Q3 2024 and 10% in Q4 2023, driven by the commission-based model for Jupiter customers.
Operational Cost Reductions
Operating expenses decreased 18% year-over-year in Q4 2024, reflecting cost reduction initiatives and improved business efficiency.
Launch of New Products and Partnerships
TILT plans to launch solventless vape products in Ohio in Q2 2025 and has received final review for QMID device certification in the EU, with commercialization expected in Q2 2025 in partnership with Curaleaf.